Real-time enrollment status for this cystic fibrosis clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 10:55 PM UTC
| NCT Number | NCT06747858 |
| Recruiting Status | Recruiting |
| Condition | Cystic Fibrosis |
| Phase | PHASE2 |
| Target Enrollment | 33 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Arcturus Therapeutics, Inc. |
| Last Updated on CT.gov | May 8, 2026 (May 8, 2026) |
As of July 19, 2026: Clinical trial NCT06747858 is currently recruiting participants. This phase2 study for cystic fibrosis is actively seeking new participants at 13 locations across the United States. The study is sponsored by Arcturus Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06747858 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06747858 was last updated May 8, 2026 (May 8, 2026). HelloStudys verifies this status automatically.